ABSTRACT
The increasing availability of genomic information coupled with the advances in predictive computational tools for characterizing structure, electrostatics, and dynamics of DNA and for estimating DNA-ligand binding free energies ushers in an era of DNA-targeted computer-aided drug discovery to combat infectious diseases and noncommunicable disorders, with higher levels of reliability.
